Key market opportunities in the global competent cells market include rising demands in genetic engineering and synthetic biology sectors, driven by advancements in molecular cloning, drug discovery, ...
Elegen sets a new benchmark for clonal, cell-free synthetic DNA with ENFINIA, delivering unmatched length and accuracy from ...
This model is suitable for investigating viral pathogenic mechanisms, gene function, and virus-host interactions. It can also be used for testing HPV-related vaccines and developing and validating ...
Identification of a nitric oxide-regulated transitional state of Müller glia reveals a key mechanism enabling neuronal regeneration in the injured vertebrate retina.
Elegen today announced significant price reductions across its ENFINIAtm DNA portfolio, now offering high-accuracy, clonal, cell-free synthetic DNA with list pricing as low as $0.07 per base pair.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results